← All companies

WHWK

Whitehawk Therapeutics, Inc.

WHWK Nasdaq Pharmaceutical Preparations EDGAR ↗

$3.96

+0.11 +2.86%

Key statistics

from XBRL data in SEC filings

Market cap

$196M

Revenue (TTM)

$0.00

Net income (TTM)

-$116M

EPS (TTM)

$-2.48

P/E ratio

—

Dividend yield

—

Free cash flow

-$98.0M

Cash

$34.8M

Total assets

$127M

Gross margin

—

52-week range

$1.57 – $5.50

Recent SEC filings

40 most recent

Annual, quarterly & current reports

8-K Shareholder vote results Jun 12, 2026 8-K Other events May 21, 2026 8-K Entered a material agreement; Unregistered sale of equity; Regulation FD disclosure May 13, 2026 10-Q Quarter ended 2026-03-31 May 7, 2026 8-K Results of operations (earnings release) May 7, 2026 10-K Fiscal year ended 2025-12-31 Mar 12, 2026 8-K Results of operations (earnings release) Mar 12, 2026 10-Q Quarter ended 2025-09-30 Nov 6, 2025 8-K Results of operations (earnings release) Nov 6, 2025 10-Q Quarter ended 2025-06-30 Aug 7, 2025 8-K Results of operations (earnings release) Aug 7, 2025 8-K Shareholder vote results Jun 13, 2025 10-Q Quarter ended 2025-03-31 May 8, 2025 8-K Results of operations (earnings release) May 8, 2025 8-K/A Mar 31, 2025 10-K Fiscal year ended 2024-12-31 Mar 28, 2025 8-K Completed an acquisition or disposition Mar 26, 2025 8-K Results of operations (earnings release); Amended charter or bylaws Mar 18, 2025 8-K Entered a material agreement; Shareholder vote results; Regulation FD disclosure Mar 4, 2025 8-K Entered a material agreement; Unregistered sale of equity; Director or officer change; Regulation FD disclosure Dec 20, 2024 10-Q Quarter ended 2024-09-30 Nov 6, 2024 8-K Results of operations (earnings release) Nov 6, 2024 8-K Other events Sep 30, 2024 8-K Director or officer change Sep 19, 2024 8-K Director or officer change Aug 22, 2024 8-K Exit or disposal costs; Other events Aug 21, 2024 10-Q Quarter ended 2024-06-30 Aug 7, 2024 8-K Results of operations (earnings release) Aug 7, 2024 8-K Shareholder vote results Jun 12, 2024 10-Q Quarter ended 2024-03-31 May 8, 2024 8-K Results of operations (earnings release) May 8, 2024 8-K Entered a material agreement Apr 4, 2024 10-K Fiscal year ended 2023-12-31 Mar 13, 2024 8-K Results of operations (earnings release) Mar 13, 2024 8-K Other events Dec 14, 2023 10-Q Quarter ended 2023-09-30 Nov 8, 2023 8-K/A Results of operations (earnings release) Nov 8, 2023 8-K Results of operations (earnings release) Nov 8, 2023 8-K Director or officer change; Regulation FD disclosure Oct 2, 2023 10-Q Quarter ended 2023-06-30 Aug 9, 2023